drugset / Trial / NCT06854783
Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
Non-randomizedSequentialOpen-labelBasic science
Summary
The purpose of this study is to assess the pharmacokinetics, safety, tolerability and food effect of investigational drug MRX1 in healthy adults.
Timeline
- Start
- 2025-07-14
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 2.5 mg/kg | Oral |
| Subject | Cannabidiol | Other / unclassified | 7.5 mg/kg | Oral |
Indications
No indication recorded.